13F Filings History of Corriente Advisors, LLC

Latest 13F report
Q3 2023 - 14 Nov 2023
Value $
$0
Signature - Title
Matthew H. Gilman - CFO / CCO
Location
Fort Worth, TX
Summary
This page shows a list of all the recent 13F filings made by Corriente Advisors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Corriente Advisors, LLC reported 2 stock holdings with total value $3,449,812 as of Q3 2023.

Notify me when Corriente Advisors, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2023 0 $0 $0 -$3,449,812 -$3,449,812 13F-HR 13 Feb 2024, 19:29
Q3 2023 2 $3,449,812 +$3,449,812 -$10,872,000 -$7,422,188 NXE, RGTIW 13F-HR 14 Nov 2023, 15:38
Q2 2023 2 $10,872,000 +$10,872,000 -$976,400 +$9,895,600 AUR, JOBY 13F-HR 08 Aug 2023, 18:59
Q1 2023 2 $976,400 +$976,400 $0 +$976,400 AI, BBAI 13F-HR 10 May 2023, 16:04
Q4 2022 0 $0 $0 $0 $0 13F-HR 15 Feb 2023, 14:53
Q3 2022 0 $0 $0 $0 $0 13F-HR 15 Nov 2022, 14:02
Q2 2022 0 $0 $0 $0 $0 13F-HR 15 Aug 2022, 18:49
Q1 2022 1 $1,622,000 +$1,622,000 -$8,331,000 -$6,709,000 NBR 13F-HR 16 May 2022, 16:20
Q4 2021 2 $8,331,000 +$8,331,000 -$51,796,000 -$43,465,000 CPG, APRN 13F-HR 15 Feb 2022, 15:06
Q3 2021 8 $51,796,000 +$30,981,000 -$166,684,219 -$135,703,219 CUE, SWN, TFFP, LTRN, VET 13F-HR 15 Nov 2021, 11:23
Q2 2021 15 $185,402,000 +$54,446,000 -$139,400,365 -$84,954,365 MAXR, CUE, REPL, COIN, RETA 13F-HR 16 Aug 2021, 09:08
Q1 2021 10 $271,579,000 +$76,642,632 -$193,929,563 -$117,286,931 MAXR, REPL, CUE, CRDF, TDY 13F-HR 18 May 2021, 09:08
Q4 2020 19 $420,091,000 +$217,731,488 -$31,541,400 +$186,190,088 MAXR, RETA, REPL, CRDF, CCJ 13F-HR 16 Feb 2021, 16:26
Q3 2020 16 $197,205,000 +$94,410,675 -$49,220,000 +$45,190,675 MAXR, RETA, CUE, APTOSE BIOSCIENCES INC, TFFP 13F-HR 03 Nov 2020, 14:50
Q2 2020 16 $154,336,000 +$64,326,764 -$29,258,272 +$35,068,492 MAXR, RETA, SONO, APTOSE BIOSCIENCES INC, CUE 13F-HR 13 Aug 2020, 17:37
Q1 2020 11 $92,638,000 +$38,953,710 -$104,798,599 -$65,844,889 RETA, MAXR, APTOSE BIOSCIENCES INC, CUE, GBTC 13F-HR 18 May 2020, 10:33
Q4 2019 16 $183,240,000 $0 $0 $0 MAXR, RETA, SPCE, QURE, TPTX 13F-HR 13 Feb 2020, 18:01